Stay informed with the latest updates for the inheritable blood disorders community. IndustryIdenix Ceases Development of Two HCV DrugsMar 1, 2013 IndustryGilead's HCV Therapy Trials On TrackMar 1, 2013 IndustryBiogen Reports A-LONG and B-LONG Studies ProgressMar 1, 2013 Advocacy & LegislativeWashington Days Focus: Hemophilia Program Funding and Specialty Tiers Bill…Feb 1, 2013 Advocacy & LegislativeBackground Information on Washington Budget PolicyFeb 1, 2013 IndustryCSL Behring Enrolls Pediatric Patient in Hemophilia B StudyFeb 1, 2013 IndustryGreen Cross Initiates Phase III Trial of rFVIII ProductFeb 1, 2013 IndustryBaxter Announces Inhibitor Study Results, Acquisition of Inspiration…Feb 1, 2013 IndustryBiogen Idec Submits FDA Application for Long-Acting FIX TherapyFeb 1, 2013 MedicalInternational Study Finds Similar Inhibitor Risk for FVIII ProductsFeb 1, 2013 MedicalResearchers Discover Genetic Links to VWFFeb 1, 2013 MedicalNew Blood Center in PhiladelphiaFeb 1, 2013 Advocacy & LegislativeNHF Comments on Essential Health Benefits RegulationJan 1, 2013 IndustryBaxter Presents Data on Developmental Recombinant FIX ProductJan 1, 2013 NBDF & CommunitySteps for Living Web Site Launches New SectionJan 1, 2013 Pagination First page Previous page … Page 78 Page 79 Page 80 Page 81 Current page 82 Page 83 Page 84 Page 85 Page 86 … Next page Last page
